Source: ERS Lung Science Conference 2021
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Yuliya Fedorchenko, Ukraine. PP306 – Submicroscopic changes of type I alveolocytes in the early stages of experimental diabetes mellitus. ERS Lung Science Conference 2021

Member's Comments

No comment yet.

Related content which might interest you: LSC - 2021 - Submicroscopic changes of type I alveolocytes in the early stages of experimental diabetes mellitus Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases Year: 2021 Submicroscopic changes of of hemomicrocirculatory bed of the lungs in long term experimental streptozotocin-induced diabetes mellitus Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases Year: 2021 Respiratory muscle function in type 2 diabetes mellitus Source: Annual Congress 2008 - Assessment of the respiratory system Year: 2008 COPD prevalence and severity is associated to type 2 diabetes mellitus complications and lack of glycometabolic control Source: Annual Congress 2008 - COPD and comorbidities Year: 2008 Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Is there any characteristics difference between pulmonary tuberculosis patients with and without diabetes mellitus type 2? Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities Year: 2009 Evidence of early abnormal airways’ inflammation in children with type 1 diabetes Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches Year: 2021 A study of the comorbidity of COPD and type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Changes in lung function in a rodent model of diabetes mellitus Source: International Congress 2018 – New methods and concepts in tests of lung and respiratory muscle function Year: 2018 Study of pulmonary function in type2 diabetes mellitus and its changes with change in duration and glycemic control Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights Year: 2012 Study of PFT‘s in patients with type 2 diabetes mellitus and diabetic neuropathy and microangiopathy Source: Annual Congress 2007 - Lung function and therapy in obstructive lung diseases Year: 2007 Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012 Peculiarities of diabetes mellitus in cystic fibrosis adults Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 The conjunctival microcirculation disturbances at COPD patients in combination with diabetes mellitus type 2 and their correction by gliclazide Source: Eur Respir J 2004; 24: Suppl. 48, 61s Year: 2004 Is lung a target organ in diabetes mellitus? Source: Eur Respir J 2002; 20: Suppl. 38, 491s Year: 2002 The association of pulmonary fibrosis with diabetes mellitus Source: ERJ Open Res, 6 (4) 00237-2020; 10.1183/23120541.00237-2020 Year: 2020 Relative risk of type 2 diabetes mellitus complications is increased in non effectively treated OSA patients Source: Eur Respir J 2005; 26: Suppl. 49, 39s Year: 2005 Sleep in type II diabetes Source: Annual Congress 2003 - Cough and sleep disorders Year: 2003 Comparison of COPD patients with and without diabetes mellitus Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Newly detected pulmonary tuberculosis in patients combined with diabetes mellitus and without it. Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019